269 related articles for article (PubMed ID: 17173233)
1. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
[TBL] [Abstract][Full Text] [Related]
2. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
3. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.
Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
6. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
Chan KC; Wong KH; Lee SS
HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
[TBL] [Abstract][Full Text] [Related]
7. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
8. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
[TBL] [Abstract][Full Text] [Related]
9. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.
Nakhaee F; Black D; Wand H; McDonald A; Law M
Sex Health; 2009 Jun; 6(2):129-34. PubMed ID: 19457292
[TBL] [Abstract][Full Text] [Related]
10. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
11. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
12. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus.
López-Gatell H; Cole SR; Hessol NA; French AL; Greenblatt RM; Landesman S; Preston-Martin S; Anastos K
Am J Epidemiol; 2007 May; 165(10):1134-42. PubMed ID: 17339383
[TBL] [Abstract][Full Text] [Related]
13. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
14. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.
Szczech LA; Hoover DR; Feldman JG; Cohen MH; Gange SJ; Goozé L; Rubin NR; Young MA; Cai X; Shi Q; Gao W; Anastos K
Clin Infect Dis; 2004 Oct; 39(8):1199-206. PubMed ID: 15486845
[TBL] [Abstract][Full Text] [Related]
15. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
16. Trends in perimortal conditions and mortality rates among HIV-infected patients.
Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
[TBL] [Abstract][Full Text] [Related]
17. Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).
Hessamfar-Bonarek M; Morlat P; Salmon D; Cacoub P; May T; Bonnet F; Rosenthal E; Costagliola D; Lewden C; Chêne G;
Int J Epidemiol; 2010 Feb; 39(1):135-46. PubMed ID: 19805489
[TBL] [Abstract][Full Text] [Related]
18. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
19. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
20. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
